Related Experiment Video
Updated: Jan 27, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Feasibility of continuous temperature monitoring in pediatric immunocompromised patients: A pilot study
Megan Sampson1, Victoria Hickey1, John Huber2
1Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Insights
Continuous temperature monitoring using TempTraq patches offers a feasible and safe way to detect fever early in immunocompromised children, improving upon standard monitoring methods. This technology aids in timely intervention, potentially reducing severe illness.
Area of Science:
- Pediatric Medicine
- Infectious Disease Monitoring
- Medical Device Technology
Background:
- Fever detection is critical for managing immunocompromised patients, as delays can increase morbidity and mortality.
- Current episodic temperature monitoring may not reliably detect or may delay fever identification in this vulnerable population.
Purpose of the Study:
- To assess the feasibility, safety, and tolerability of continuous temperature monitoring using the TempTraq patch in pediatric patients.
- To compare the efficacy of continuous monitoring with standard episodic monitoring for fever detection.
Main Methods:
- A pilot study involving ten pediatric patients.
- Continuous temperature monitoring was conducted for 5 days using TempTraq patches.
- Data was compared against standard episodic temperature monitoring (standard of care).
Main Results:
- TempTraq successfully detected fever in two patients missed by episodic monitoring.
- Significant delays (>12 hours) in fever detection were observed with episodic monitoring in two cases, which TempTraq identified promptly.
- Caregivers found the TempTraq patch to be tolerable and easy to apply.
Conclusions:
- Continuous temperature monitoring with TempTraq is a feasible, safe, and well-tolerated method for pediatric patients.
- TempTraq demonstrates superior performance in early fever detection compared to standard episodic monitoring in immunocompromised children.
- This technology holds promise for improving clinical management and outcomes in pediatric patients at risk for febrile episodes.
Abstract:
Early recognition of fever is paramount in reducing morbidity and mortality in immunocompromised patients. We performed a pilot study to determine the feasibility, safety, and tolerability of continuous temperature monitoring via TempTraq, a continuous temperature monitoring patch. Ten pediatric patients were enrolled and received continuous temperature monitoring over 5 days in addition to episodic monitor (standard of care). Episodic monitoring failed to detect fever in two patients and there was a significant delay (>12 h) of fever detection in two others that was detected with TempTraq. Additionally, caregivers reported TempTraq was tolerable and easy to apply.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pilot and Numeric Relaying
Continuing Care

